All stock lists
Nomura Holdings Inc (New York Stock Exchange:NMR)
JP · Delayed Price · Currency is USD
Financial Services · Financial - Capital Markets
8.99+0.01 (+0.11%)
Market cap
$26.3B
Health Score
Analyst consensus
Listed since
Dec 14, 2001
Website
Insider Score
––Not scored
NMR Insider Score
Insiders here have filed 12 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
NMR analyst forecast
Best analysts covering NMR
No firm covering NMR has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
NMR analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | JP Morgan | Overweight | — | — | Upgraded | 2026-03-19 |
| — | Jefferies | Hold | — | — | Downgraded | 2023-01-25 |
| — | Goldman Sachs | Neutral | — | — | Downgraded | 2021-03-30 |
| — | Goldman Sachs | Buy | — | — | Upgraded | 2021-03-09 |
| — | Jefferies | Hold | — | — | Upgraded | 2016-09-01 |
| — | JP Morgan | Neutral | — | — | Upgraded | 2016-07-29 |
| — | Jefferies | Neutral | — | — | Downgraded | 2016-06-27 |
| — | Credit Suisse | Neutral | — | — | Downgraded | 2016-02-10 |
| — | Deutsche Bank | Hold | — | — | Downgraded | 2016-02-08 |
| — | Jefferies | Hold | — | — | Downgraded | 2016-02-08 |
| — | UBS | Neutral | — | — | Downgraded | 2015-07-22 |
| — | Barclays | Equal Weight | — | — | Upgraded | 2015-06-23 |
| — | Credit Suisse | Neutral | — | — | Downgraded | 2014-05-14 |
| — | Morgan Stanley | Overweight | — | — | Upgraded | 2013-03-21 |
| — | Macquarie | Outperform | — | — | Upgraded | 2013-02-14 |
NMR earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-01-30 | 0.24 | 0.18 | $3.31B | $3.54B |
| 2026-04-24 | 0.21 | 0.16 | $3.37B | $3.62B |
| 2026-07-29 | 0.23 | 0.30 | $3.49B | $4.31B |
| 2026-10-28 | 0.20 | 0.00 | $4.12B | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.